Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Alvarez

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
CNS & Neurological Disorders Drug Targets|February 23, 2018
VaD - An Integrated Framework for Cognitive RehabilitationMaria Balea, Dafin Muresanu, Anton Alvarez, et al.
Journal of Alzheimer'S Disease : JAD|September 26, 2022
Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and DonepezilX Anton Alvarez, Charisse N Winston, James W Barlow, et al.
The International Journal of Neuropsychopharmacology|July 9, 2020
Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's DiseaseX Anton Alvarez, Irene Alvarez, Antia Martinez, et al.
The International Journal of Neuropsychopharmacology|May 22, 2016
Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 CasesX Anton Alvarez, Irene Alvarez, Olalla Iglesias, et al.
CNS & Neurological Disorders Drug Targets|August 20, 2021
Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in VietnamLuc Tran, X Anton Alvarez, Hoang-Anh Le, et al.
CNS & Neurological Disorders Drug Targets|May 1, 2015
A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injuryDafin F Muresanu, Alexandru V Ciurea, Radu M Gorgan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
CNS & Neurological Disorders Drug Targets|February 23, 2018
VaD - An Integrated Framework for Cognitive RehabilitationMaria Balea, Dafin Muresanu, Anton Alvarez, et al.
Journal of Alzheimer'S Disease : JAD|September 26, 2022
Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and DonepezilX Anton Alvarez, Charisse N Winston, James W Barlow, et al.
The International Journal of Neuropsychopharmacology|July 9, 2020
Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's DiseaseX Anton Alvarez, Irene Alvarez, Antia Martinez, et al.
The International Journal of Neuropsychopharmacology|May 22, 2016
Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 CasesX Anton Alvarez, Irene Alvarez, Olalla Iglesias, et al.
CNS & Neurological Disorders Drug Targets|August 20, 2021
Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in VietnamLuc Tran, X Anton Alvarez, Hoang-Anh Le, et al.
CNS & Neurological Disorders Drug Targets|May 1, 2015
A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injuryDafin F Muresanu, Alexandru V Ciurea, Radu M Gorgan, et al.
Pageof 2